Overview
LANXESS is a specialty chemicals company that develops, manufactures, and sells chemical intermediates, additives, and consumer-protection products. Its products act as building blocks and functional additives used in coatings, plastics, consumer goods, and other formulations to improve performance and protection. The company differentiates itself through a strong sustainability focus, holding leading positions in indices such as the Dow Jones Sustainability Index and ESG ratings, and maintaining a global footprint with about 12,500 employees in 32 countries. LANXESS aims to deliver high-quality specialty chemicals while advancing sustainable chemistry and meeting environmental, social, and governance standards.
Work here?Claim your company
Simplify's take
What believers are saying
- November 5, 2026 Q3 sales rose 9.6% and EBITDA preexceptionals rose 11.2%.
- Management lifted 2026 EBITDA guidance to the upper end of €450 million to €500 million.
- Free cash flow turned positive to €48 million in Q3 2026, improving liquidity.
What critics are saying
- LANXESS cut 550 jobs on March 19, 2026, signaling structural demand weakness.
- 2025 revenue fell 10.9% to €5.673 billion, showing fragile pricing and volume power.
- If Saltigo restructuring and Envalior monetization stall, LANXESS faces prolonged margin compression and strategic drift.
What makes LANXESS unique
- LANXESS’s Saltigo and specialties portfolio gives higher-value exposure than commodity chemical peers.
- Matthias Zachert’s FORWARD! program has delivered roughly €150 million annual savings by 2025.
- Envalior’s €4 billion engineering-materials platform preserves optionality for monetization and balance-sheet support.
Help us improve and share your feedback! Did you find this helpful?